Search
Search Results
##search.searchResults.foundPlural##
-
-
DONOR KIR3DL1/RECEPTOR HLA-BW4-80I COMBINATION REDUCES ACUTE LEUKEMIA RELAPSE AFTER UMBILICAL CORD BLOOD TRANSPLANTATION WITHOUT IN VITRO T-CELL DEPLETION KIR3DL1 with HLA-Bw4-80I reduces leukemia relapse
1402PDF: 547HTML: 209 -
Skin Manifestations associated with Mantle cell Lymphoma: a case report
1572PDF: 768HTML: 2148Untitled: 227Untitled: 199Untitled: 197Untitled: 206Untitled: 201 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2198PDF: 1610HTML: 312 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2487HTML: 281PDF: 888 -
EVALUATION OF THE PLASMA MICRO RNA EXPRESSION LEVELS IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
1405PDF: 699HTML: 1100Untitled: 186Untitled: 153Untitled: 136Untitled: 157Untitled: 165 -
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL
1657PDF: 1105HTML: 127 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1602PDF: 624HTML: 212 -
RECENT ADVANCES IN THE 5Q- SYNDROME
2811PDF: 1839HTML: 3686Pellagatti Fig 1: 222Pellagatti Fig. 2: 216 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1576PDF: 1042HTML: 238 -
CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS CAR-T and Follicular Lymphoma
2344PDF: 1860HTML: 148 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4354PDF: 1521HTML: 1555Untitled: 239 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2108PDF: 1167HTML: 647 -
COST OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN INDIA
2777PDF: 975HTML: 4708 -
Monocyte HLA-Dr Expression to Monitor Immune Response and Potential Infection Risks Following Vaso-Occlusive Crises in Patients with Sickle Cell Anemia Monocyte HLA-DR expression in SCA patients
714PDF: 551HTML: 220 -
Simultaneous dual pathology in lymph node
1668PDF: 700HTML: 7719Simultaneous dual pathology in lymph node: 177Simultaneous dual pathology in lymph node: 178Simultaneous dual pathology in lymph node: 153Simultaneous dual pathology in lymph node: 191Simultaneous dual pathology in lymph node: 179 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
1970PDF: 1181HTML: 275 -
MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.
4700PDF: 1330HTML: 1918Untitled: 184Untitled: 179 -
REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2348PDF: 1001HTML: 7629Untitled: 283Fig2: 186Fig3: 174Fig4: 184 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4136PDF: 1953HTML: 5325Table 1: 201 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3942PDF: 1492HTML: 8518 -
QUALITY OF LIFE ASSESSMENT IN MULTIPLE MYELOMA PATIENTS UNDERGOING DOSE-REDUCED TANDEM AUTOLOGOUS STEM CELL TRANSPLANTATION
1415PDF: 692HTML: 1381cover letter: 214 -
Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure Memory Cell Population Of Natural Killer Cells in COVID-19 and Cytomegalovirus Exposure
1205PDF: 928HTML: 290 -
BACK TO THE “GOLD STANDARD”: HOW PRECISE IS HEMATOCRIT DETECTION TODAY? Novel ImageJ-based approach for the precise hematocrit measurement
2254PDF: 848HTML: 501 -
CORD BLOOD PLATELET LYSATE: IN VITRO EVALUATION TO SUPPORT THE USE IN REGENERATIVE MEDICINE. Cord and adult blood platelet lysates
2065PDF: 1150HTML: 253







